Vimarsana
Biggest News Aggregation in the World

Retrieved August News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Retrieved August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Retrieved August Today - Breaking & Trending Today

Building Quality into Biologic Production to Meet Regulations - Vimarsana News

Building Quality into Biologic Production to Meet Regulations

A look at how the industry is focusing on quality and sterility into DPs to ensure patient safety in the pharmaceutical industry.

WaveDancer Announces Merger Agreement with Firefly - Vimarsana News

WaveDancer Announces Merger Agreement with Firefly

– Merger to create NASDAQ-listed, commercial-stage AI-Enabled medical technology company focused on bringing FDA-cleared Brain Network Analytics platform...

Addressing Mental Health Disparities in Black Women - Vimarsana News

Addressing Mental Health Disparities in Black Women

Pharmacists are accessible and trusted health care professionals who have an important role in supporting people living with mental illness.

LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections - Vimarsana News

LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

SCHLIEREN, Switzerland, October 09, 2023--LimmaTech Biologics AG today announced the closing of a USD 37 million (CHF 33 million) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund. The proceeds will enable LimmaTech to advance its proprietary technology platform and accelerate its pipeline of preclinical and clinical vaccine candidates against increasingly dangerous bacterial infections, including programs addressing shigellosis and gonorr

Source: yahoo.com
LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidru - Vimarsana News

LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidru

SCHLIEREN, Switzerland--(BUSINESS WIRE)--LimmaTech Biologics AG today announced the closing of a USD 37 million (CHF 33 million) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund. The proceeds will enable LimmaTech to advance its proprietary technology platfor...